VYNE Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: VYNE Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: VYNE Therapeutics Inc
Rating: 0.92908325
Author: Trendlyne DVM scores

about

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated fo...

0.40 -1.04 (-72.22%)

New 52W Low today

37.9M

XNAS Volume

High volume+loss today

XNAS 30 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

22.3 / 100

Technically Bearish

14.8 / 100

1Yr Price target upside is 1495%

4 analysts

VYNE Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VYNE Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated fo...

New 52W Low today

High volume+loss today

SWOT Analysis

VYNE Therapeutics Inc Live Price Chart